SRTA - Strata Critical Medical, Inc.
NEXT EARNINGS:
Mar 12, 2026
(in 30 days)
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.25
DETAILS
HIGH:
$7.25
LOW:
$7.25
MEDIAN:
$7.25
CONSENSUS:
$7.25
UPSIDE:
59.34%
Market Cap:
392.97M
Volume:
517,744
Avg Volume:
934,119
52 Week Range:
2.35-6.02
Sector:
Industrials
Industry:
Airlines, Airports & Air Services
Beta:
-0.21
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
310
IPO Date:
2019-11-05
EPS (TTM):
-0.35
P/E Ratio:
-12.06
Revenue (TTM):
248.69M
Total Assets:
256.68M
Total Debt:
9.32M
Cash & Equiv:
18.38M
Rev Growth (5Y):
48.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-14.5%
Debt/Equity:
0.04
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 248.69M | 225.18M | 146.12M | 50.53M | 23.43M | 31.20M |
| Net Income | (27.31M) | (56.08M) | (27.26M) | (40.05M) | (10.16M) | (10.84M) |
| EPS | -0.35 | -0.76 | -0.38 | -0.57 | -0.81 | -1.47 |
| Total Assets | 256.68M | 294.94M | 325.02M | 335.88M | 17.71M | 277.69M |
| Total Debt | 9.32M | 24.52M | 18.33M | 716,000 | 1.89M | 462,732 |
| Cash & Equivalents | 18.38M | 27.87M | 41.34M | 2.60M | 12.16M | 1.31M |
| Operating Cash Flow | (2.52M) | (32.35M) | (37.13M) | (15.62M) | (10.82M) | (10.30M) |
| Free Cash Flow | (35.51M) | (34.46M) | (37.86M) | (16.42M) | (11.20M) | (11.16M) |
| FCF per Share | -0.46 | -0.47 | -0.53 | -0.23 | -0.89 | -1.52 |
| Book Value | 221.94M | 234.30M | 274.49M | 291.37M | 11.08M | 5.00M |
| Cash & ST Investments | 127.14M | 166.14M | 192.08M | 281.97M | 12.16M | 277.57M |
| ROC Equity | -0.12 | -0.24 | -0.10 | -0.14 | -0.92 | -2.17 |